Related Experiment Video
Updated: May 27, 2026

06:38
Determination of Reproductive Competence by Confirming Pubertal Onset and Performing a Fertility Assay in Mice and Rats
Published on: October 13, 2018
Advanced reproductive age and fertility
1Toronto ON.
Summary
Female fertility naturally declines with age, impacting both natural conception and assisted reproductive technologies (ART). Awareness and timely intervention are crucial for managing age-related infertility risks in women and men.
Area of Science:
- Reproductive endocrinology and infertility
- Maternal-fetal medicine
- Genetics and aging
Background:
- Fertility in both women and men naturally decreases with advancing age.
- This age-related decline affects outcomes for both natural conception and assisted reproductive technologies (ART).
- Ovarian aging is a significant factor in female fertility reduction.
Purpose of the Study:
- To enhance understanding of age-related fertility decline in females and males.
- To review methods for assessing ovarian reserve and fertility treatments.
- To provide evidence-based recommendations for managing infertility in advanced reproductive age.
Main Methods:
- Systematic literature search of PubMed, Medline, CINAHL, and Cochrane Library up to December 2010.
- Inclusion of systematic reviews, RCTs, CCTs, and observational studies.
- Quality of evidence and recommendations ranked using the Canadian Task Force on Preventive Health Care criteria.
Main Results:
- Ovarian reserve testing has limited predictive value for pregnancy, primarily useful for excluding specific cases.
- Pregnancy rates with ART, except egg donation, are significantly lower for women in their late 30s and 40s.
- Advanced maternal and paternal age are associated with increased risks of pregnancy complications and offspring conditions.
Conclusions:
- Counseling on age-related infertility risks should be integrated into routine reproductive healthcare for women in their 20s and 30s.
- Women over 35 should undergo infertility work-up after 6 months of trying; ovarian reserve testing can be considered for specific risk factors.
- Oocyte donation is the most effective treatment for ovarian aging; advanced paternal age carries small but notable risks that warrant counseling.
More Related Videos
Related Concept Videos
Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Nondisjunction
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Spermatogenesis
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...

